About Par Formulations Private Limited
Data last updated: 06 January 2026
Par Formulations Private Limited is a private limited company based in Chennai, Tamil Nadu, India, a subsidiary of Par Pharmaceuticals Inc.. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 22 September 1982, the company has been in operation for over 44 years.
Registered with ROC Chennai under CIN U33111TN1982PTC009602.
Capital: an authorised share capital of ₹2.2 Cr and a paid-up capital of ₹2.14 Cr. Formerly known as Novel Therapeutics Private Limited and Edict Pharmaceuticals Private Limited. It is led by directors Chitti Babu Sampath Kumar and Anand Amrit Raj.
Last AGM: 26 September 2024. Financial statements filed for year ended 31 March 2024. Office: 9/215 Pudupakkam – Vandalur Main Road Pudupakkam Kelambakkam, Chennai, Tamil Nadu, India – 603103.
As per the financials filed for FY 2025, the company reported a revenue of ₹1,462.09 Cr, a growth of 5% compared to the previous year.
The company has a workforce of approximately 1,304 employees as per the latest available data. It operates as a subsidiary of Par Pharmaceuticals Inc.. Its group structure includes 2 subsidiaries.
The company is associated with 2 brands - Endo International, Par Pharmaceutical Companies. As per MCA filings, the company has open charges of ₹17.13 Lakh and satisfied charges of ₹62.37 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website parpharm.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social MediaLocked
-
Registered Address9/215 Pudupakkam – Vandalur Main Road Pudupakkam Kelambakkam, Chennai, Tamil Nadu, India – 603103
-
IndustryPharma, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Name History of Par Formulations Private Limited
Par Formulations Private Limited has undergone 4 name changes throughout its history. The current legal name is Par Formulations Private Limited, reflecting the company's evolution and rebranding over time.
| Company Name | Status |
|---|---|
| Par Formulations Private Limited | Current |
| Novel Therapeutics Private Limited | Previous |
| Edict Pharmaceuticals Private Limited | Previous |
| Chk Electroniks Private Limited | Previous |
| Ch Krishnan And Associates Private Limited | Previous |
Associated Brands with Par Formulations Private Limited
Par Formulations Private Limited operates two associated brands: Endo International and Par Pharmaceutical Companies. These brands represent Par Formulations Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Global pharmaceutical company manufacturing branded, generic formulations, and OTC medicines | endo.com | |
| Pharmaceutical products are developed for endocrinology, orthopedics, and urology. | parpharm.com |
Competitors & Alternatives of Par Formulations Private Limited
Brands and companies operating in the same space as Par Formulations Private Limited include Merck, Roivant Sciences, AbbVie and 7 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Merck
|
Pharmaceutical products are manufactured and marketed worldwide. | Kenilworth, United Kingdom, United Kingdom | 1891 |
Roivant Sciences
|
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | New York, United States, United States | 2014 |
AbbVie
|
Biopharmaceutical research and drug development are conducted globally by AbbVie. | Chicago, United States, United States | 2012 |
Lilly
|
Traditional pharmaceutical medicines are developed for multiple health fields. | United States | 1876 |
Gilead
|
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | Foster City, United States, United States | 1987 |
United Therapeutics
|
Treatments for chronic and life-threatening diseases are developed and commercialized. | Silver Spring, United States, United States | 1998 |
Roche
|
Pharmaceuticals and diagnostics kits are developed for various diseases. | Basel, Switzerland, Switzerland | 1896 |
Ascendis Pharma
|
Long-acting prodrug therapies are developed for endocrine and rare diseases. | Hellerup, Denmark, Denmark | 2007 |
MorphoSys
|
Therapeutic antibodies for cancer and other diseases are developed. | Planegg, Germany, Germany | 1992 |
Vertex Pharmaceuticals
|
Developer of drugs for the treatment of multiple disorders | United States | 1989 |
Business Activity of Par Formulations Private Limited
Par Formulations Private Limited is engaged in principal business activities including manufacturing and professional, scientific and technical, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products, scientific research and development. The company has 2 registered principal business activity segments, demonstrating its operational diversity and market reach.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
| M | Professional, Scientific and Technical | M5 | Scientific research and development | Locked |
Business activity turnover details for Par Formulations Private Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Par Formulations Private Limited
Par Formulations Private Limited is audited by Price Waterhouse & Co Chartered Accountants LLP for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Price Waterhouse & Co Chartered Accountants LLP | Locked | Locked | Locked |
Complete auditor history for Par Formulations Private Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Par Formulations Private Limited
Par Formulations Private Limited is currently managed by 2 directors, with 25 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chitti Babu Sampath Kumar | Whole-Time Director | 28 Jun 2017 | 9 Years 1 Months | Current |
| Anand Amrit Raj | Director | 27 May 2022 | 4 Years 2 Months | Current |
Financials of Par Formulations Private Limited FY 2024 filings available
Par Formulations Private Limited reported revenue of ₹1,462.09 Cr (up 5.00% YoY) for FY 2025.
Ten-year financial statements for Par Formulations Private Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Par Formulations Private Limited
Shareholding and ownership data for Par Formulations Private Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Group Structure of Par Formulations Private Limited
Par Formulations Private Limited has 2 subsidiary companies. This group structure data is as of FY 2023. The corporate group structure reflects Par Formulations Private Limited's business expansion strategy and organizational complexity.
| Company Name | CIN | Shares Held |
|---|---|---|
| Par Active Technologies Private Limited | U24232TN2013PTC093471 | Locked |
| Par Biosciences Private Limited | U24233TN2012PTC086326 | Locked |
Showing major subsidiaries. Total: 2.
Charges & Borrowings of Par Formulations Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Aug 2022 | Others | ₹12.13 Lakh | Open |
| 08 Aug 2022 | Others | ₹5 Lakh | Open |
| 08 Aug 2022 | Others | ₹27.06 Cr | Satisfied |
| 04 Feb 2010 | State Bank of India | ₹18 Cr | Satisfied |
| 06 Mar 2008 | State Bank of India | ₹15 Cr | Satisfied |
Total charge records: 10 View all charges
Employees and EPFO Compliance at Par Formulations Private Limited
Par Formulations Private Limited has a workforce of 1,304 employees as of Apr 05, 2024.
Employee and EPFO history for Par Formulations Private Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Par Formulations Private Limited
GST registrations and filing compliance for Par Formulations Private Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Par Formulations Private Limited
Credit ratings, litigation, and regulatory alerts for Par Formulations Private Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Par Formulations Private Limited
MSME payment history for Par Formulations Private Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Par Formulations Private Limited
Corporate group structure for Par Formulations Private Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Par Formulations Private Limited
MCA filings and documents for Par Formulations Private Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Par Formulations Private Limited
Frequently Asked Questions about Par Formulations Private Limited
Par Formulations Private Limited is an active private limited company in the pharma sector based in Chennai, Tamil Nadu, India. It was incorporated on 22 September 1982 (44+ years old) and is registered under CIN U33111TN1982PTC009602. The company has 1,304 employees.
Par Formulations Private Limited reported revenue of ₹1,462.09 Cr for FY 2025 (up 5.00% YoY).
The current directors of Par Formulations Private Limited are:
- Chitti Babu Sampath Kumar - Whole-Time Director
- Anand Amrit Raj - Director
The primary industry of Par Formulations Private Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.
Par Formulations Private Limited can be reached at the registered office: 9215 Pudupakkam – Vandalur Main Road Pudupakkam Kelambakkam, Chennai, Tamil Nadu, India – 603103, or through the website parpharm.com.
The authorised capital is ₹2.2 Cr, and the paid-up capital is ₹2.14 Cr.